Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-07-05

Clinical Trial Update: A Study to Learn About How Food and Esomeprazole Affect the Level of BAY2927088 in the Blood When Taken Together in Healthy Participants [Phase 1]

View source ↗

Summary

Phase 1 study to evaluate how food and the proton pump inhibitor esomeprazole affect BAY2927088 blood levels in healthy participants.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BAY2927088
  • Esomeprazole (Esomeprazole)

Snippet

Sponsor: Bayer | Conditions: Advanced Non-small Cell Lung Cancer, EGFR Mutation | Phase 1 | Status: COMPLETED